No chance against RMS? [Regulatives / Guidelines]

posted by ElMaestro  – Belgium?, 2010-08-10 16:26  – Posting: # 5765
Views: 9,862

Dear Dan,

Under the first point I think I would add that you have not (have you?) received questions for module 3 and specifications; thus, the potential variability from the studies reflects -at least in part- the natural variation within the specifications that the M3 assessor has accepted.

You are right, a referral will not be triggered if the RMS disagrees. This is a new thing and there is very little you can do. If the RMS enforces a principle that has never been defined in a guideline document and which is not in line with contemporary equivalence thinking then honestly I think this would be a case for the European Generics Association. This is a slow process and not one that can be expected to work here and now.
Having said that, I am pretty sure regulators from BfArM are seeing this thread and giving it some consideration. That would potentially be in your favour.

I actually still believe your product is alive.

I could be wrong, but...
Best regards,

Complete thread:

 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,888 posts in 4,215 threads, 1,364 registered users;
online 7 (0 registered, 7 guests [including 6 identified bots]).
Forum time (Europe/Vienna): 22:23 CEST

The real purpose of the scientific method is to make sure
nature hasn’t misled you into thinking you know something
you actually don’t know.    Robert M. Pirsig

BEBAC Ing. Helmut Schütz